Zacks.com on MSN1h
Wall Street Analysts Predict a 25.59% Upside in BioNTech (BNTX): Here's What You Should Know
The average of price targets set by Wall Street analysts indicates a potential upside of 25.6% in BioNTech (BNTX). While the effectiveness of this highly sought-after metric is questionable, the ...
Sarepta Therapeutics: Guidance Suggests A Year Of Upside Likely
Sarepta Therapeutics' Elevidys for DMD shows revenue potential, with market cap justified at $11.4bn and potential for >50% ...
marketinference2m
M&T Bank Q4 2024 Net Income Drops
The net interest margin narrowed from 3.62% in the third quarter of 2024 to 3.58% in the fourth quarter of 2024. The ...